These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16982462)

  • 1. Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.
    Wang L; Shao ZM
    Cancer Invest; 2006 Oct; 24(6):581-7. PubMed ID: 16982462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of cyclin E expression in breast cancer: a meta-analysis.
    Gao S; Ma JJ; Lu C
    Tumour Biol; 2013 Dec; 34(6):3423-30. PubMed ID: 23775012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of cyclin E in low-risk node negative breast cancer.
    Ahlin C; Gruhne B; Holmqvist M; Zetterberg A; Fjällskog ML
    Acta Oncol; 2008; 47(8):1539-45. PubMed ID: 18607847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [P27Kip1 expression and its prognostic implication in breast carcinoma: a meta-analysis].
    Xie RL; Guan XX; Chen LB; Wang JH; Bai JL; Zhu BL; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):92-8. PubMed ID: 18681319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.
    Span PN; Tjan-Heijnen VC; Manders P; Beex LV; Sweep CG
    Oncogene; 2003 Jul; 22(31):4898-904. PubMed ID: 12894232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
    Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer.
    Kühling H; Alm P; Olsson H; Fernö M; Baldetorp B; Parwaresch R; Rudolph P
    J Pathol; 2003 Apr; 199(4):424-31. PubMed ID: 12635132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of cyclin E expression in operable breast cancer.
    Potemski P; Kusińska R; Pasz-Walczak G; Piekarski JH; Watała C; Płuciennik E; Bednarek AK; Kordek R
    Med Sci Monit; 2009 Feb; 15(2):MT34-40. PubMed ID: 19179977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.
    Lundgren C; Ahlin C; Holmberg L; Amini RM; Fjällskog ML; Blomqvist C
    Acta Oncol; 2015 Apr; 54(4):538-44. PubMed ID: 25327158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.
    Kim HK; Park IA; Heo DS; Noh DY; Choe KJ; Bang YJ; Kim NK
    Eur J Surg Oncol; 2001 Aug; 27(5):464-71. PubMed ID: 11504517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.
    Sieuwerts AM; Look MP; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; de Weerd V; Portengen H; Klijn JG; Foekens JA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3319-28. PubMed ID: 16740753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Claudins as prognostic factors of breast cancer].
    Szász MA
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.
    Waltersson MA; Askmalm MS; Nordenskjöld B; Fornander T; Skoog L; Stål O
    Int J Oncol; 2009 Feb; 34(2):441-8. PubMed ID: 19148479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
    Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.
    Berglund P; Stighall M; Jirström K; Rydén L; Fernö M; Nordenskjöld B; Landberg G
    J Clin Pathol; 2008 Feb; 61(2):184-91. PubMed ID: 17483245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.
    Lindahl T; Landberg G; Ahlgren J; Nordgren H; Norberg T; Klaar S; Holmberg L; Bergh J
    Carcinogenesis; 2004 Mar; 25(3):375-80. PubMed ID: 14633656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients.
    Desmedt C; Ouriaghli FE; Durbecq V; Soree A; Colozza MA; Azambuja E; Paesmans M; Larsimont D; Buyse M; Harris A; Piccart M; Martiat P; Sotiriou C
    Int J Cancer; 2006 Dec; 119(11):2539-45. PubMed ID: 16929516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.
    Sun X; Zhangyuan G; Shi L; Wang Y; Sun B; Ding Q
    Medicine (Baltimore); 2017 May; 96(19):e6860. PubMed ID: 28489780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.